Zobrazeno 1 - 10 of 33 pro vyhledávání: '"Jambon-Barbara C"'
2
Akademický článek
Regional Heterogeneity of the Results of Glucagon-Like Peptide 1 Receptor Agonist Trials in Type 2 Diabetes: A Reanalysis of Individual Participant Data.
Autor: Jullien A; INSERM, CIC1406, University of Grenoble Alpes, Grenoble, France., Jambon-Barbara C; INSERM, CIC1406, University of Grenoble Alpes, Grenoble, France.; INSERM, U1300, HP2, University of Grenoble Alpes, Grenoble, France., Cracowski JL; INSERM, CIC1406, University of Grenoble Alpes, Grenoble, France.; INSERM, U1300, HP2, University of Grenoble Alpes, Grenoble, France., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Borel AL; INSERM, U1300, HP2, University of Grenoble Alpes, Grenoble, France.; Endocrinology Diabetology & Nutrition Department, Grenoble Alpes University Hospital, Grenoble, France., Khouri C; INSERM, CIC1406, University of Grenoble Alpes, Grenoble, France.; INSERM, U1300, HP2, University of Grenoble Alpes, Grenoble, France., Roustit M; INSERM, CIC1406, University of Grenoble Alpes, Grenoble, France.; INSERM, U1300, HP2, University of Grenoble Alpes, Grenoble, France.
Publikováno v: Diabetes care [Diabetes Care] 2024 Nov 01; Vol. 47 (11), pp. 1949-1957.
Zobrazit plný text záznamu
3
Akademický článek
Development and validation of a code-based algorithm using in-hospital medical records to identify patients with pulmonary arterial hypertension in a French healthcare database.
Autor: Jambon-Barbara C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Hlavaty A; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Bernardeau C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France., Bouvaist H; Cardiology Unit, Grenoble Alpes University Hospital, Grenoble, France., Chaumais MC; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Pharmacy, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Faculty of Pharmacy, Université Paris-Saclay, Saclay, France., Humbert M; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Faculty of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital Bicêtre, DMU 5 Thorinno, Le Kremlin-Bicêtre, France., Montani D; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Faculty of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital Bicêtre, DMU 5 Thorinno, Le Kremlin-Bicêtre, France., Cracowski JL; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Khouri C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France.; Grenoble Alpes University Hospital, Clinical Pharmacology Department INSERM CIC1406, Grenoble, France.
Publikováno v: ERJ open research [ERJ Open Res] 2024 Aug 12; Vol. 10 (4). Date of Electronic Publication: 2024 Aug 12 (Print Publication: 2024).
Zobrazit plný text záznamu
4
Akademický článek
Use of Bisphosphonates and the Risk of Skin Ulcer: A National Cohort Study Using Data from the French Health Care Claims Database.
Autor: Jambon-Barbara C; Pharmacovigilance Department, Grenoble Alpes University Hospital, 38043, Grenoble, France., Bernardeau C; Pharmacovigilance Department, Grenoble Alpes University Hospital, 38043, Grenoble, France., Bezin J; University Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Clinical Pharmacology Unit, CHU de Bordeaux, 33000, Bordeaux, France., Roustit M; University Grenoble Alpes, Inserm U1300, HP2, 38000, Grenoble, France.; University Grenoble Alpes, Inserm CIC1406, Grenoble Alpes University Hospital, 38000, Grenoble, France., Blaise S; University Grenoble Alpes, Inserm U1300, HP2, 38000, Grenoble, France.; Department of Vascular Medicine, Grenoble Alpes University Hospital, University Grenoble Alpes, 38000, Grenoble, France., Cracowski JL; Pharmacovigilance Department, Grenoble Alpes University Hospital, 38043, Grenoble, France.; University Grenoble Alpes, Inserm U1300, HP2, 38000, Grenoble, France., Khouri C; Pharmacovigilance Department, Grenoble Alpes University Hospital, 38043, Grenoble, France. ckhouri@chu-grenoble.fr.; University Grenoble Alpes, Inserm U1300, HP2, 38000, Grenoble, France. ckhouri@chu-grenoble.fr.; University Grenoble Alpes, Inserm CIC1406, Grenoble Alpes University Hospital, 38000, Grenoble, France. ckhouri@chu-grenoble.fr.; Centre Regional de Pharmacovigilance, CHU Grenoble Alpes, CS 10217, 38043, Grenoble Cedex 9, France. ckhouri@chu-grenoble.fr.
Publikováno v: Drug safety [Drug Saf] 2023 Sep; Vol. 46 (9), pp. 905-916. Date of Electronic Publication: 2023 Aug 02.
Zobrazit plný text záznamu
5
Editorial & Opinion
Validity, relevance and interpretation of pharmacovigilance disproportionality analyses.
Autor: Cortes B; Pharmacy Department, Grenoble Alpes University Hospital, F-38000 Grenoble, France., Jambon-Barbara C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, F-38000 Grenoble, France; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Cracowski JL; Pharmacovigilance Unit, Grenoble Alpes University Hospital, F-38000 Grenoble, France; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Khouri C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, F-38000 Grenoble, France; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France. Electronic address: CKhouri@chu-grenoble.fr.
Publikováno v: Bone [Bone] 2023 May; Vol. 170, pp. 116685. Date of Electronic Publication: 2023 Feb 08.
Zobrazit plný text záznamu
6
Akademický článek
Understanding the variability of pharmaco-epidemiological studies assessing the risk of appendicitis with mRNA COVID-19 vaccines.
Autor: Jambon-Barbara C; Pharmacovigilance Department, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, Inserm U1300, HP2, Grenoble, France., Bernardeau C; Pharmacovigilance Department, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, Inserm U1300, HP2, Grenoble, France., Cracowski JL; Pharmacovigilance Department, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, Inserm U1300, HP2, Grenoble, France., Khouri C; Pharmacovigilance Department, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, Inserm U1300, HP2, Grenoble, France.; Univ. Grenoble Alpes, Inserm CIC1406, Grenoble Alpes University Hospital, F-38000, Grenoble, France.
Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Jan; Vol. 32 (1), pp. 87-90. Date of Electronic Publication: 2022 Nov 18.
Zobrazit plný text záznamu
7
Akademický článek
Placebo response in Raynaud's Phenomenon clinical trials: The prominent role of regression towards the mean: Placebo response in Raynaud's Phenomenon.
Autor: Roustit M; Univ. Grenoble Alpes, Inserm U1300, 38000 Grenoble, France; Univ. Grenoble Alpes, Inserm CIC 1406, CHU Grenoble Alpes, 38000 Grenoble, France. Electronic address: MRoustit@chu-grenoble.fr., Jullien A; Univ. Grenoble Alpes, Inserm CIC 1406, CHU Grenoble Alpes, 38000 Grenoble, France., Jambon-Barbara C; Univ. Grenoble Alpes, Inserm CIC 1406, CHU Grenoble Alpes, 38000 Grenoble, France., Goudon H; Univ. Grenoble Alpes, Inserm CIC 1406, CHU Grenoble Alpes, 38000 Grenoble, France., Blaise S; Univ. Grenoble Alpes, Inserm U1300, 38000 Grenoble, France; Department of Vascular Medicine, CHU Grenoble Alpes, 38000 Grenoble, France., Cracowski JL; Univ. Grenoble Alpes, Inserm U1300, 38000 Grenoble, France; Univ. Grenoble Alpes, Inserm CIC 1406, CHU Grenoble Alpes, 38000 Grenoble, France., Khouri C; Univ. Grenoble Alpes, Inserm U1300, 38000 Grenoble, France; Univ. Grenoble Alpes, Inserm CIC 1406, CHU Grenoble Alpes, 38000 Grenoble, France.
Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2022 Dec; Vol. 57, pp. 152087. Date of Electronic Publication: 2022 Aug 27.
Zobrazit plný text záznamu
8
Akademický článek
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems.
Autor: Cutroneo, Paola Maria1 (AUTHOR), Sartori, Daniele2 (AUTHOR), Tuccori, Marco3 (AUTHOR) marco.tuccori@gmail.com, Crisafulli, Salvatore4 (AUTHOR), Battini, Vera5 (AUTHOR), Carnovale, Carla5 (AUTHOR), Rafaniello, Concetta6 (AUTHOR), Capuano, Annalisa6 (AUTHOR), Poluzzi, Elisabetta7 (AUTHOR), Moretti, Ugo4 (AUTHOR), Raschi, Emanuel7 (AUTHOR)
Publikováno v: Frontiers in Drug Safety & Regulation. 2024, p1-15. 15p.
Zobrazit plný text záznamu
9
Akademický článek
Editorial: Traditional and innovative approaches for signal detection.
Autor: Tuccori, Marco1 (AUTHOR) marco.tuccori@gmail.com, Bate, Andrew2,3 (AUTHOR), Moretti, Ugo4 (AUTHOR), Trifirò, Gianluca4 (AUTHOR)
Publikováno v: Frontiers in Drug Safety & Regulation. 2024, p1-3. 3p.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje